Denali Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

MUN:4DN Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Feb 24	Sell€43,809	Alexander Schuth	Individual	2,716	€16.13
13 Feb 24	Sell€44,905	Carole Ho	Individual	2,784	€16.13
13 Feb 24	Sell€154,669	Ryan Watts	Individual	9,589	€16.13
13 Feb 24	Sell€44,357	Steve Krognes	Individual	2,750	€16.13
10 Jan 24	Sell€80,999	Carole Ho	Individual	4,668	€17.35
09 Jan 24	Sell€141,527	Ryan Watts	Individual	7,818	€18.10
05 Jan 24	Sell€309,768	Ryan Watts	Individual	17,483	€17.72
05 Jan 24	Sell€176,686	Alexander Schuth	Individual	9,972	€17.72
05 Jan 24	Sell€56,840	Steve Krognes	Individual	3,208	€17.72
05 Jan 24	Sell€176,686	Carole Ho	Individual	9,972	€17.72
21 Aug 23	Sell€29,456	Steve Krognes	Individual	1,419	€20.76
21 Aug 23	Sell€47,909	Ryan Watts	Individual	2,309	€20.75
21 Aug 23	Sell€51,416	Alexander Schuth	Individual	2,478	€20.75
21 Aug 23	Sell€51,439	Carole Ho	Individual	2,478	€20.76
10 Aug 23	Sell€62,625	Alexander Schuth	Individual	2,853	€21.95
10 Aug 23	Sell€62,635	Carole Ho	Individual	2,857	€21.92

Insider Trading Volume

Insider Buying: 4DN insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 4DN?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	5,877	0.00412%
Individual Insiders	6,693,364	4.7%
General Public	12,128,008	8.51%
Public Companies	12,751,365	8.95%
Institutions	110,960,915	77.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.2%.

Top Shareholders

Top 25 shareholders own 74.21% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.85%	Baillie Gifford & Co.	14,041,228	€223.4m	-1.54%	0.11%
8.95%	Biogen Inc.	12,751,365	€202.9m	0%	no data
8.1%	BlackRock, Inc.	11,543,446	€183.7m	6.05%	no data
7.6%	The Vanguard Group, Inc.	10,834,483	€172.4m	2.23%	no data
5.1%	Wellington Management Group LLP	7,274,717	€115.8m	-0.2%	0.02%
4.84%	Temasek Holdings (Private) Limited	6,895,992	€109.7m	0%	0.12%
3.97%	Crestline Investors Inc.	5,660,732	€90.1m	-5.03%	8.72%
3.85%	State Street Global Advisors, Inc.	5,485,948	€87.3m	28.3%	no data
2.16%	T. Rowe Price Group, Inc.	3,073,290	€48.9m	-13.2%	no data
2.04%	Capital Research and Management Company	2,909,528	€46.3m	1.01%	no data
1.87%	Geode Capital Management, LLC	2,659,296	€42.3m	5.03%	no data
1.83%	Baker Bros. Advisors LP	2,607,196	€41.5m	13.8%	0.53%
1.63%	Flagship Pioneering, Inc	2,319,968	€36.9m	-11.4%	2.35%
1.57%	Ryan Watts	2,238,471	€35.6m	-0.18%	no data
1.48%	Marc Tessier-Lavigne	2,107,225	€33.5m	0%	no data
1.24%	BNY Mellon Asset Management	1,762,829	€28.1m	-5.1%	0.01%
1.17%	Marshall Wace LLP	1,667,397	€26.5m	0%	0.06%
1.07%	Credit Suisse Asset Management (Switzerland) Ltd.	1,521,552	€24.2m	0.47%	0.02%
0.95%	Federated Hermes, Inc.	1,351,900	€21.5m	0%	0.06%
0.91%	Casdin Capital, LLC	1,300,000	€20.7m	0%	1.78%
0.86%	Gilder Gagnon Howe & Co. LLC	1,219,392	€19.4m	-2.15%	0.27%
0.81%	Norges Bank Investment Management	1,152,646	€18.3m	12.5%	no data
0.81%	Yiheng Capital Management, L.P.	1,150,684	€18.3m	0%	2.1%
0.79%	Principal Global Investors, LLC	1,123,342	€17.9m	4.54%	0.01%
0.79%	Dimensional Fund Advisors LP	1,119,628	€17.8m	15%	no data